Breast Cancer AR Navigation
SKIA Breast
Accuracy of the Safest Standard
Source: SKIA White Paper
SKIA Breast strives for a safe and accurate navigation for soft tissues.
With 1.7 mm accuracy, SKIA can safely guide surgeons to the breast cancer tissues.
Visualizing lesions in AR can boost surgeons' confidence and accuracy.
SKIA Breast is currently going through clinical trials and awaiting KMFDS approval. It is not available for sale.
Plan Your Surgery
SKIA provides your own DICOM viewer to view and plan your surgery. It is equipped with automatic and powerful tools that help you make the best clinical decisions before going into surgery. SKIA Processor is essential to construct 3D models of skin, bone, organs, and blood vessels.
3D Modeling
Surgeons can use the SKIA Processor to first mark the breast lesions. Once the markings are done, SKIA Processor reconstructs the DICOM data into 3D models containing breast lesions. This process does not interrupt the original workflow and can be done within minutes.
Easy Registration
SKIA's AI-integrated matching system allows the registration to be under 5 seconds. Simply scan the patient, and the AI will analyze the environment in real-time and register the patient. The learning curve is extremely short thanks to the power of SKIA's artificial intelligence.
See Beyond the Surface
SKIA's augmented reality allows you to dive deep into the patient's anatomy. The mobile nature of SKIA's device allows you to look around the patient quickly. The shortest depth to the lesions can instantly be identified and aid in the surgical planning process.
Stepping Closer to Reality
SKIA Breast is the first navigation system for breast cancer.
We have successfully completed the exploratory clinical trial in 2022
and now facing the final confirmatory clinical trial with
Ewha Womans University Hospital, SNU Hospital, and Yonsei Severance Hospital.
